The case for therapeutic overactivation of oncogenic signaling as a potential cancer treatment strategy.

Cancer Cell

Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address:

Published: June 2024

Most targeted cancer drugs inhibit the oncogenic signals to which cancer cells are addicted. We discuss here a counterintuitive approach to cancer therapy, which consists of deliberate overactivation of the oncogenic signals to overload the stress responses of cancer cells. We discuss why such overactivation of oncogenic signaling, combined with perturbation of the stress response pathways, can be potentially effective in killing cancer cells, aiming to inspire further discussion and consideration.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2024.04.014DOI Listing

Publication Analysis

Top Keywords

overactivation oncogenic
12
cancer cells
12
oncogenic signaling
8
oncogenic signals
8
cancer
6
case therapeutic
4
therapeutic overactivation
4
oncogenic
4
signaling potential
4
potential cancer
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!